Predictions
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€69.50
14.12.20
14.12.20
-
14.12.21
14.12.21
-16.69%
19.04.21
19.04.21
Voyager Therapeutics Inc
Start price
Target price
Perf. (%)
€6.65
13.12.20
13.12.20
-
10.53%
14.01.21
14.01.21
Risky Investment
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€24.58
13.12.20
13.12.20
-
-10.62%
14.01.21
14.01.21
Could be worthwhile Investment >10% per year
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€3.06
13.12.20
13.12.20
-
13.12.21
13.12.21
1.50%
11.03.21
11.03.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Ionis Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€37.79
13.12.20
13.12.20
-
13.12.21
13.12.21
-29.55%
14.12.21
14.12.21
Risky Investment
Glycomimetics Inc.
Start price
Target price
Perf. (%)
€3.00
13.12.20
13.12.20
€4.20
13.12.21
13.12.21
-53.33%
14.12.21
14.12.21
Tenax Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.80
13.12.20
13.12.20
€24.00
13.12.21
13.12.21
15.73%
14.12.21
14.12.21
Dare Bioscience Inc.
Start price
Target price
Perf. (%)
€1.06
13.12.20
13.12.20
€1.20
13.12.21
13.12.21
47.17%
14.12.21
14.12.21
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€142.00
13.12.20
13.12.20
€170.00
13.12.21
13.12.21
9.00%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€133.02
13.12.20
13.12.20
€165.00
13.12.21
13.12.21
12.43%
27.04.21
27.04.21
Curis Inc.
Start price
Target price
Perf. (%)
€6.35
13.12.20
13.12.20
-
13.12.21
13.12.21
37.01%
16.02.21
16.02.21
Below average Marketposition
Probably not worthwhile Investment
Significant cyclical dependencies
Little known brand
Lexicon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.66
13.12.20
13.12.20
-
13.12.21
13.12.21
143.95%
16.02.21
16.02.21
Probably not worthwhile Investment
Significant cyclical dependencies
PhaseBio Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.60
12.12.20
12.12.20
-
12.12.21
12.12.21
-42.22%
13.12.21
13.12.21
Probably not worthwhile Investment
Burcon Nutrascience Corp.
Start price
Target price
Perf. (%)
€1.91
12.12.20
12.12.20
-
12.12.21
12.12.21
47.01%
09.01.21
09.01.21
Risky Investment
Acelrx Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.07
12.12.20
12.12.20
-
12.12.21
12.12.21
-5.77%
09.01.21
09.01.21
Risky Investment
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€395.05
12.12.20
12.12.20
-
12.12.21
12.12.21
4.78%
09.01.21
09.01.21
Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Formycon AG
Start price
Target price
Perf. (%)
€65.20
12.12.20
12.12.20
-
12.12.21
12.12.21
-7.06%
11.03.21
11.03.21
Could be worthwhile Investment >10% per year